Compound ID | 98
Class: Efflux pump inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors |
| Combined with other compounds: | Yes |
| Institute where first reported: | Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.03535-14 |